Statera BioPharma (STU:7CB) Land And Improvements : €0.00 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Land And Improvements?

Statera BioPharma's land and improvements for the quarter that ended in Sep. 2022 was €0.00 Mil.

Statera BioPharma Land And Improvements Historical Data

The historical data trend for Statera BioPharma's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Land And Improvements Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Land And Improvements

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Land And Improvements	Get a 7-Day Free Trial						-	-	-	-	-

Statera BioPharma Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Statera BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma Headlines

No Headlines